News & Media
MD Anderson News & Media
Histone modification regulates CD8+ T cell activity, suggesting new treatment strategies
MD Anderson Research Highlights for October 16, 2024
Targeting KDM6B-mediated epigenetic machinery overcomes immunotherapy resistance in glioblastoma
MD Anderson Research Highlights for September 21, 2023
Allison Institute announces appointment of inaugural members
MD Anderson Newsroom, May 2023
Physician-scientist driven to improve treatment options for kidney and bladder cancer patients
MD Anderson Cancerwise, January 2023
MD Anderson announces 2021 class of Andrew Sabin Family Fellows
MD Anderson Newsroom, July 2021
Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
MD Anderson Newsroom, June 2020
Researchers identify immune-suppressing target in glioblastoma
MD Anderson Newsroom, December 2019
External News & Media
-
Metabolic–epigenetic rewiring in CD8+ T cells via lactate-dependent histone lactylation
Nature Immunology News & Views, October 2024
-
Understanding histone lactylation to enhance immunotherapy
ACIR Weekly Digests, October 2024
-
Pioneering Immuno-Oncology Through a Love of Science
Technology Networks: Cancer Research, May 2024
-
Dr. Goswami's Oncology Journey: Patient-centric Science and Mentorship Stories
OncLive, April 2024
-
Sangeeta Goswami, MD, PhD – Leading the Way in Translational Clinical Trials for Kidney, Bladder Cancer
GU Oncology Now, February 2024
-
Macrophage targeting in brain cancer
Science: In Other Journals, September 2023
-
KDM6B-mediated reprogramming of myeloid cells regulates the response to immunotherapy
Nature Cancer Research Briefing, September 2023
-
Kidney Cancer Breakout: New treatments to preserve quality of life
Cancer Research Institute (YouTube), November 2022
-
Sangeeta Goswami, MD, PhD, CLIP Investigator
Cancer Research Funded Institute, 2021